Irinotecan Hydrochloride
NDC 63323-193, IRINOTECAN HYDROCHLORIDE, injection, solution, from Fresenius Kabi USA, LLC.
- Product NDC
- 63323-193
- Status
- Listed
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077776
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63323-193 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IRINOTECAN HYDROCHLORIDE20 mg/mL
Pharmacologic classes
Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63323-193-52 | 63323019352 | 1 VIAL in 1 BOX (63323-193-52) / 2 mL in 1 VIAL |
| 63323-193-55 | 63323019355 | 1 VIAL in 1 BOX (63323-193-55) / 5 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ee45f127-8450-4455-a945-a1f5707f1d39Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=63323-193
Use it
Look up 63323-193 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63323-193 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63323-193. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.